2021.09.13 Press release

--To the press -

FRONTEO Starts Academic Activities Based on Medical Perspectives for Academia on Natural Language AI Technology Development

Regional IPA / JPS Meeting ・ 36th Annual Meeting of the Japanese Geriatric Psychiatry

FRONTEO Inc.
Masahiro Morimoto, President and CEO
東京 都 港区 港 南 2-12-23
(Code number: 2158 TSE Mothers)

 FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) will hold the 9th Regional IPA / JPS Meeting from September 16th (Thursday) to 18th (Saturday). The Japanese Psychogeria Society will hold a co-sponsored seminar on the theme of "The Future of Dementia Diagnosis-How Diagnosis Will Change with the World's First Language-based AI Medical Device".

 

[Seminar Outline]
Theme: The Future of Dementia Diagnosis-How Diagnosis Will Change with the World's First Language-based AI Medical Device
Date and time: Friday, September 2021, 9 17: 12-50: 13
Meeting place: WEB held (For detailsSociety homepagePlease check more)
Lecture XNUMX: Artificial intelligence diagnosed by natural conversation-Challenge ahead of the world-
Lecture XNUMX: Prospects and issues of diagnosis of dementia using AI

* Information about this seminar
 Registration to attend the conference is required for viewing.
 Participants will be informed of the viewing site / WEB viewing method by the academic society.

 

 FRONTEO has been developing solutions for AI medical devices and software in the life science field, using the artificial intelligence "Concept Encoder (trademark: concept encoder, reading: concept encoder)" developed in-house as its core technology.Furthermore, since industry-academia collaboration between the AI ​​field and the medical field will be extremely important in the future, technical and academic information on this technology will be provided to academia (medical society, etc.) including the neuropsychiatric field in earnest. We have decided to disseminate information to.This co-sponsored seminar will be held as part of this information dissemination activity. FRONTEO will contribute to the more effective use of AI in the medical field and the promotion of digitalization of medical care in Japan.

 


■ About Concept Encoder
 URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO URL:https://www.fronteo.com/
FRONTEO uses the self-developed AI engine "KIBIT" and "Concept Encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. , A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

* FRONTEO, conceptencoder, and KIBIT are registered trademarks of FRONTEO in Japan.

<Contact information for the press>

Public Relations Officer, FRONTEO Inc.

E-mail: pr_contact@fronteo.com

 

<Inquiries about Life Science AI Business>

FRONTEO Inc. Life Science AI Business Headquarters

https://lifescience.fronteo.com/contact

ja 日本語
Machine Translation by Google. : close x